Severe hyperthermia during tetrabenazine therapy for tardive dyskinesia

Intensive Care Medicine

Volumn 24, Issue 4, 1998, Pages 369-371

  Stevens, E ^a   Roman, A ^a   Houa, M ^a   Razavi, D ^a   Jaspar, N ^a  

^a SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Clomipramine; Hyperthermia; Neuroleptic malignant syndrome; Tardive dyskinesia; Tetrabenazine

Indexed keywords

ANTIDEPRESSANT AGENT; BROMOCRIPTINE; CLOMIPRAMINE; DANTROLENE; LORAZEPAM; MIANSERIN; NEUROLEPTIC AGENT; TETRABENAZINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CYTOLYSIS; DEPRESSION; HUMAN; HYPERTHERMIA; LIVER CELL; MALE; MENTAL DISEASE; NEUROLEPTIC MALIGNANT SYNDROME; ORAL DRUG ADMINISTRATION; PARENTERAL DRUG ADMINISTRATION; PSYCHOSIS; RECTUM TEMPERATURE; RHABDOMYOLYSIS; TARDIVE DYSKINESIA;

ANTI-ANXIETY AGENTS; ANTI-DYSKINESIA AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CLOMIPRAMINE; DRUG THERAPY, COMBINATION; DYSKINESIA, DRUG-INDUCED; FEVER; HUMANS; LORAZEPAM; MALE; MIANSERIN; MIDDLE AGED; TETRABENAZINE;

EID: 0031922718     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001340050583     Document Type: Article

References (10)

1. Burke RE, Fahn S, Mayeux R, Weinberg H, Louis K, Willner JH (1981) Neuroleptic malignant syndrome caused by dopamine-depleting drugs in a patient with Huntington disease. Neurology 31: 1022-1026
2. Mateo D, Munoz-Blanco JL, Gimenez-Roldan S (1992) Neuroleptic malignant syndrome related to tetrabenazine introduction and haloperidol discontinuation in Huntington's disease. Clin Neuropharmacol 15: 63-68
3. Osseman M, Sindic CJM, Laterre C (1996) Tetrabenazine as a cause of neuroleptic malignant syndrome. Move Disord 11: 95
4. Petzinger G, Bressman SB (1997) A case of tetrabenazine-induced neuroleptic malignant syndrome after prolonged treatment. Move Disord 12: 246-248
5. Jankovic J, Beach J (1997) Long term effects of tetrahenazine in hyperkinetic movement disorders. Neurology 48: 358-362
6. Baca L, Martinelli L (1990) Neuroleptic malignant syndrome: a unique association with a tricyclic antidepressant. Neurology 40: 1797-1798
7. Lejoyeux M, Rouillon F, Ades J (1993) Prospective evaluation of the serotonin syndrome in depressed inpatients treated with clomipramine. Acta Psychiatr Scand 88: 369-371
8. François B, Marquet P, Desachy A, Roustan J, Lachatre G, Gastinne H (1997) Serotonin syndrome due to an overdose of moclobemide and clomipramine. Intensive Care Med 23: 122-124
9. Bodner RA, Lynch T, Lewis L, Kahn D (1995) Serotonin syndrome. Neurology 45: 219-223
10. Roberts M, McLean S, Millingen K, Galloway H (1986) The pharmacokinetics of tetrabenazine and its hydroxy metabolite in patients treated for involuntary movement disorders. Eur J Clin Pharmacol 29: 703-708